SOMALOGIC INC (SLGC) Stock Price & Overview

NASDAQ:SLGC • US83444K1051

Current stock price

2.1 USD
-0.1 (-4.55%)
At close:
2 USD
-0.1 (-4.76%)
After Hours:

The current stock price of SLGC is 2.1 USD. Today SLGC is down by -4.55%. In the past month the price decreased by -22.51%. In the past year, price decreased by -19.54%.

SLGC Key Statistics

52-Week Range1.73 - 3.79
Current SLGC stock price positioned within its 52-week range.
1-Month Range1.93 - 2.74
Current SLGC stock price positioned within its 1-month range.
Market Cap
396.228M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.69
Dividend Yield
N/A

SLGC Stock Performance

Today
-4.55%
1 Week
-21.05%
1 Month
-22.51%
3 Months
-0.94%
Longer-term
6 Months -3.67%
1 Year -19.54%
2 Years -75.52%
3 Years N/A
5 Years N/A
10 Years N/A

SLGC Stock Chart

SOMALOGIC INC / SLGC Daily stock chart

SLGC Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SLGC. When comparing the yearly performance of all stocks, SLGC is a bad performer in the overall market: 78% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SLGC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SLGC. No worries on liquidiy or solvency for SLGC as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SLGC Earnings

Next Earnings DateMar 26, 2024
Last Earnings DateNov 8, 2023
PeriodQ3 / 2023
EPS Reported-$0.12
Revenue Reported
EPS Surprise 30.80%
Revenue Surprise 5.58%

SLGC Forecast & Estimates

10 analysts have analysed SLGC and the average price target is 4.01 USD. This implies a price increase of 91.05% is expected in the next year compared to the current price of 2.1.

For the next year, analysts expect an EPS growth of -2.43% and a revenue growth -12.14% for SLGC


Analysts
Analysts80
Price Target4.01 (90.95%)
EPS Next Y-2.43%
Revenue Next Year-12.14%

SLGC Groups

Sector & Classification

Index Membership

SLGC Financial Highlights

Over the last trailing twelve months SLGC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS decreased by -50% compared to the year before.


Income Statements
Revenue(TTM)81.73M
Net Income(TTM)-130.38M
Industry RankSector Rank
PM (TTM) N/A
ROA -23.08%
ROE -26.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%33.33%
Sales Q2Q%-47.13%
EPS 1Y (TTM)-50%
Revenue 1Y (TTM)-19.73%

SLGC Ownership

Ownership
Inst Owners0.05%
Shares188.68M
Float175.53M
Ins Owners0.46%
Short Float %N/A
Short RatioN/A

About SLGC

Company Profile

SLGC logo image SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in Boulder, Colorado and currently employs 451 full-time employees. The company went IPO on 2021-02-23. The firm has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.

Company Info

IPO: 2021-02-23

SOMALOGIC INC

C/O Somalogic, Inc., 2945 Wilderness Place

Boulder COLORADO US

Employees: 451

SLGC Company Website

Phone: 13036259000

SOMALOGIC INC / SLGC FAQ

Can you describe the business of SOMALOGIC INC?

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in Boulder, Colorado and currently employs 451 full-time employees. The company went IPO on 2021-02-23. The firm has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.


Can you provide the latest stock price for SOMALOGIC INC?

The current stock price of SLGC is 2.1 USD. The price decreased by -4.55% in the last trading session.


Does SOMALOGIC INC pay dividends?

SLGC does not pay a dividend.


What is the ChartMill rating of SOMALOGIC INC stock?

SLGC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the employee count for SLGC stock?

SOMALOGIC INC (SLGC) currently has 451 employees.


Can you provide the market cap for SOMALOGIC INC?

SOMALOGIC INC (SLGC) has a market capitalization of 396.23M USD. This makes SLGC a Small Cap stock.